Drug repurposing of ERK inhibitors to target the transcription factor Nfix in dystrophic muscles: development of a new proof-of-concept study to hinder Muscular Dystrophies (1° anno)

Project

Overview

Contributors

MESSINA GRAZIELLA   Scientific Manager  

Departments involved

Dipartimento di Bioscienze   Principale  

Type

INTLI - Finanziamenti internazionali

Funder

AFM-TELETHON - ASS. FRANCAISE CONTRE LES MYOPATHIES
External Organization Funding Organization

Date/time interval

September 1, 2020 - August 31, 2021

Project duration

12 months

Research Areas

Concepts


Settore BIO/17 - Istologia